Dark

LMNX
Defiance Daily Target 2x Long LMND ETF
stock NASDAQ ETF

Market Open

Jun 30, 2026 3:00:33 PM EDT

16.00USD+6.454%(+0.97)20,097

15.67Bid 16.24Ask 0.57Spread

Pre-market

0.00USD-100.000%(-15.03)0

After-hours

Jun 29, 2026 4:42:30 PM EDT

15.00USD-0.200%(-0.03)0

OverviewHistoricalExchangesShortsNews

Jul 12, 2021

06:27PM EDT Middlesex Water Set to Join S&P SmallCap 600 PR Newswire

Jun 8, 2021

08:56AM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds CLDR, LMNX, DTRC, and XEC GlobeNewswire Inc

Jun 1, 2021

12:15PM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds AMRB, LMNX, CADE, and NUAN GlobeNewswire Inc

May 20, 2021

04:30PM EDT Luminex Corporation Declares Second Quarter Cash Dividend PR Newswire

Apr 14, 2021

08:22PM EDT LUMINEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Luminex Corporation - LMNX Business Wire

Apr 13, 2021

11:59AM EDT Piper Sandler Downgrades Luminex to Neutral, Lowers Price Target to $37 Benzinga

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021 Benzinga

07:47AM EDT BTIG Downgrades Luminex to Neutral Benzinga

Apr 12, 2021

11:24AM EDT DiaSorin S.p.A. Monday announced that it has agreed to acquire Luminex Corp. (LMNX) for $1.8 billion, through which it will improve its presence in the U.S. RTTNews

11:05AM EDT DiaSorin To Buy Luminex For $37.00/shr Or Approximately US$1.8 Bln RTTNews

10:55AM EDT DiaSorin Reports On Earlier Reported Deal With Luminex To Acquire Co. For $37/Share Benzinga

10:52AM EDT DiaSorin to acquire Luminex Corporation for USD 37.00 per share or PR Newswire

09:55AM EDT Price Over Earnings Overview: Luminex Benzinga

07:37AM EDT DiaSorin Acquires COVID-19 Test Maker Luminex For $37 Per Share Benzinga

06:00AM EDT A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Edges Higher Benzinga

Apr 11, 2021

04:45PM EDT Diasorin to Acquire Luminex Corporation for $37/Share; Approximately $1.8B; Luminex Shares Closed at $32.95 on Friday Benzinga

Mar 23, 2021

10:21AM EDT Analyzing Luminex's Ex-Dividend Date Benzinga

Mar 10, 2021

07:14AM EST Luminex Corporation (LMNX) announced that it has submitted Emergency Use Authorization application to the U.S. Food and Drug Administration for the company's new Aries Flu A/B & RSV+SARS-CoV-2 assay. RTTNews

06:37AM EST Luminex Submits Joint SARS-CoV-2 And Flu/RSV Respiratory Panel To FDA For Emergency Use Authorization Benzinga

06:30AM EST Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for PR Newswire

Mar 9, 2021

11:35AM EST Luminex Corporation to Participate at the 2021 Barclays Global Healthcare PR Newswire

Mar 4, 2021

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

06:47AM EST Luminex Corp. (LMNX) said it has received Emergency Use Authorization from the FDA for a new expanded version of NxTAG Respiratory Pathogen Panel that includes the SARS-CoV-2 virus for high-throughput respiratory testing. Luminex Corp. said the NxTAG RPP + SARS-CoV-2 Assay is expected to detect new variants of the coronavirus. RTTNews

06:33AM EST Luminex Gets Emergency Use Authorization From FDA For New Expanded Version Of NxTAG Respiratory Pathogen Panel RTTNews

06:31AM EST Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 Benzinga

06:30AM EST Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded PR Newswire

Feb 19, 2021

07:54AM EST Luminex Secures BARDA Funding To Develop And Validate Flu/COVID-19 Combo Respiratory Panel Benzinga

07:18AM EST Luminex Receives $11.3M In Funding From BARDA to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel Benzinga

06:37AM EST Luminex Gets $11.3 Mln BARDA Funding To Support Development And Validation Of Test Combining SARS-CoV-2 And Flu/RSV RTTNews

06:30AM EST Luminex Receives BARDA Funding to Support Development and Validation of Test PR Newswire

Feb 8, 2021

04:20PM EST Recap: Luminex Q4 Earnings Benzinga

04:03PM EST Luminex Reaffirms FY21 Sales Guidance Of $480M vs $474.36M Est. Benzinga

04:02PM EST Luminex Q4 EPS $0.01 May Not Compare To $0.13 Estimate, Sales $111.40M Beat $104.57M Estimate Benzinga

04:01PM EST Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results PR Newswire

01:05PM EST Luminex Corp. Declares Q1 Dividend Of $0.10/share, Payable April 15/ Record March 25 RTTNews

01:00PM EST Luminex Corporation Declares First Quarter Cash Dividend PR Newswire

04:04AM EST Earnings Scheduled For February 8, 2021 Benzinga

Feb 5, 2021

10:11AM EST Luminex's Earnings: A Preview Benzinga

Jan 27, 2021

07:00AM EST Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, PR Newswire

Jan 13, 2021

11:15AM EST Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference PR Newswire

Jan 12, 2021

06:06AM EST Luminex Reports Q4 Revenue Of About $111 Mln, Up About 23% From Last Year RTTNews

06:00AM EST Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue PR Newswire

Dec 21, 2020

10:14AM EST Ex-Dividend Date Insight: Luminex Benzinga

Dec 16, 2020

02:24PM EST Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference PR Newswire

Dec 7, 2020

11:04AM EST Luminex Declares Quarterly Dividend Of $0.10/share, Payable Jan. 14/ Record Dec. 23 RTTNews

11:00AM EST Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire

Nov 30, 2020

11:29AM EST Luminex Corp Director Eck Buys 4,487 Shares @Avg Price of $22.40/Share Benzinga

Nov 5, 2020

04:16PM EST Luminex Q3 EPS $0.04 Misses $0.20 Estimate, Sales $106.10M Beat $105.02M Estimate Benzinga

04:02PM EST Luminex Corporation Reports Strong Third Quarter 2020 Results PR Newswire

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 22, 2020

07:01AM EDT Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, PR Newswire

Oct 7, 2020

07:04AM EDT Luminex Posts Q3 Revenues Of About $106 Mln, Up About 35% RTTNews

07:03AM EDT Luminex Sees Prelim. Q3 Sales $106M vs $105.02M Est. Benzinga

07:01AM EDT Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue PR Newswire

Sep 24, 2020

04:06PM EDT Luminex Receives BARDA Award To Support 510(k) Filing For NxTAG Respiratory Pathogen Panel That Includes Coronavirus; Award Total $5.389M Benzinga

04:05PM EDT Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory PR Newswire

Sep 23, 2020

04:07PM EDT Luminex Receives $683.5K BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test Benzinga

04:05PM EDT Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex PR Newswire

Sep 15, 2020

07:32AM EDT Luminex Declares Q3 Cash Dividend Of $0.09/Shr; Record Sept 24/payable Oct 15 RTTNews

07:30AM EDT Luminex Corporation Declares Third Quarter Cash Dividend PR Newswire

Aug 4, 2020

04:36PM EDT Luminex: Q2 Earnings Insights Benzinga

04:15PM EDT Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board PR Newswire

04:11PM EDT Luminex Sees Q3 Sales At or Above $100M Vs. $89.47M Est.; Sees FY20 Sales At or Above $415M Vs. $386.99M Est. Benzinga

04:10PM EDT Luminex Q2 EPS $0.27 Beats $0.08 Estimate, Sales $109.50M Beat $107.33M Estimate Benzinga

04:01PM EDT Luminex Corporation Reports Second Quarter 2020 Results PR Newswire

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 22, 2020

06:18AM EDT Luminex Corp. (LMNX) announced Wednesday that it has submitted an Emergency Use Authorization or EUA request to the FDA for a new expanded version of its NxTAG Respiratory Pathogen Panel or RPP to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. RTTNews

05:29AM EDT Luminex Files for Emergency Use Authorization With FDA for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 Benzinga

05:04AM EDT Luminex Submits EUA Request To FDA For Expanded NxTAG Respiratory Pathogen Panel To Include SARS-CoV-2 Virus RTTNews

05:00AM EDT Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory PR Newswire

Jul 20, 2020

01:17PM EDT Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, PR Newswire

06:35AM EDT A Peek Into The Markets: US Stock Futures Edge Lower; Crude Oil Down 1% Benzinga

05:48AM EDT Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test Benzinga